Bacteriophage K antimicrobial-lock technique for treatment of staphylococcus aureus central venous catheter-related infection: A leporine model efficacy analysis

Journal of Vascular and Interventional Radiology

Volumn 25, Issue 10, 2014, Pages 1627-1632

  Lungren, Matthew P ^a   Donlan, Rodney M ^b   Kankotia, Ravi ^c   Paxton, Ben E ^c   Falk, Irene ^c   Christensen, Diana ^c   Kim, Charles Y ^c  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL COLONIZATION; BACTERIOPHAGE; BACTERIOPHAGE K ANTIMICROBIAL LOCK THERAPY; BACTERIUM CULTURE; BLOOD CULTURE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETER INFECTION; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; JUGULAR VEIN; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NONHUMAN; PERIPHERAL VEIN; RABBIT MODEL; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS INFECTION; VIROTHERAPY; ADVERSE EFFECTS; ANIMAL; BIOFILM; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERIZATION; DEVICES; DISEASE MODEL; EQUIPMENT DESIGN; GENETICS; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; RABBIT; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIROLOGY;

ANIMALS; BACTERIOPHAGES; BIOFILMS; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CENTRAL VENOUS CATHETERS; DISEASE MODELS, ANIMAL; EQUIPMENT DESIGN; FEMALE; JUGULAR VEINS; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84908152367     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2014.06.009     Document Type: Article

References (30)

1. M.K. Kay, T.C. Erwin, R.J. McLean, and G.M. Aron Bacteriophage ecology in Escherichia coli and Pseudomonas aeruginosa mixed-biofilm communities Appl Environ Microbiol 77 2011 821 829
2. J.A. Ferreira, J.H. Carr, C.E. Starling, M.A. de Resende, and R.M. Donlan Biofilm formation and effect of caspofungin on biofilm structure of Candida species bloodstream isolates Antimicrob Agents Chemother 53 2009 4377 4384
3. S. Cicalini, F. Palmieri, and N. Petrosillo Clinical review: new technologies for prevention of intravascular catheter-related infections Crit Care 8 2004 157 162
4. C.A. Umscheid, M.D. Mitchell, J.A. Doshi, R. Agarwal, K. Williams, and P.J. Brennan Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs Infect Control Hosp Epidemiol 32 2011 101 114
5. R.A. Schoot, E.C. van Dalen, C.H. van Ommen, and M.D. van de Wetering Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancer Cochrane Database Syst Rev 6 2013 CD008975
6. J.C. O'Horo, G.L. Silva, and N. Safdar Anti-infective locks for treatment of central line-associated bloodstream infection: a systematic review and meta-analysis Am J Nephrol 34 2011 415 422
7. I.D. Maya, D. Carlton, E. Estrada, and M. Allon Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report Am J Kidney Dis 50 2007 289 295
8. Z. Krishnasami, D. Carlton, and L. Bimbo Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution Kidney Int 61 2002 1136 1142
9. M. Snaterse, W. Ruger, W.J. Scholte Op Reimer, and C. Lucas Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials J Hosp Infect 75 2010 1 11
10. J.C. Hockenhull, K. Dwan, and A. Boland The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation Health Technol Assess 12 2008 1 154 iii-iv, xi-xii
11. C. Vuong, S. Kocianova, Y. Yao, A.B. Carmody, and M. Otto Increased colonization of indwelling medical devices by quorum-sensing mutants of Staphylococcus epidermidis in vivo J Infect Dis 190 2004 1498 1505
12. J.A. Capdevila, J. Gavalda, and J. Fortea Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique Clin Microbiol Infect 7 2001 206 212
13. S. Bassetti, J. Hu, R.B. D'Agostino Jr, and R.J. Sherertz Prolonged antimicrobial activity of a catheter containing chlorhexidine-silver sulfadiazine extends protection against catheter infections in vivo Antimicrob Agents Chemother 45 2001 1535 1538
14. M.D. van de Wetering, and J.B. van Woensel Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients Cochrane Database Syst Rev 1 2007 CD003295
15. R. Miedzybrodzki, W. Fortuna, B. Weber-Dabrowska, and A. Gorski Phage therapy of staphylococcal infections (including MRSA) may be less expensive than antibiotic treatment Postepy Hig Med Dosw (Online) 61 2007 461 465
16. B. Weber-Dabrowska, M. Mulczyk, and A. Gorski Bacteriophage therapy of bacterial infections: an update of our institute's experience Arch Immun Ther Exp (Warsz) 48 2000 547 551
17. B. Weber-Dabrowska, M. Dabrowski, and S. Slopek Studies on bacteriophage penetration in patients subjected to phage therapy Arch Immun Ther Exp (Warsz) 35 1987 563 568
18. S. Slopek, B. Weber-Dabrowska, M. Dabrowski, and A. Kucharewicz-Krukowska Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986 Arch Immun Ther Exp (Warsz) 35 1987 569 583
19. M.P. Lungren, D. Christensen, R. Kankotia, I. Falk, B.E. Paxton, and C.Y. Kim Bacteriophage K for reduction of biofilm on central venous catheter material Bacteriophage 3 2013 e26825
20. W. Fu, T. Forster, O. Mayer, J.J. Curtin, S.M. Lehman, and R.M. Donlan Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system Antimicrob Agents Chemother 54 2010 397 404
21. J.J. Curtin, and R.M. Donlan Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis Antimicrob Agents Chemother 50 2006 1268 1275
22. M. Obuchowski, and M. Stopa Quick and efficient method for recovering of bacteriophages from soft agar after their propagation by the plate lysate technique Acta Biochim Pol 40 1993 98 99
23. M.H. Adams The stability of bacterial viruses in solutions of salts J Gen Physiol 32 1949 579 594
24. S.T. Abedon, S.J. Kuhl, B.G. Blasdel, and E.M. Kutter Phage treatment of human infections Bacteriophage 1 2011 66 85
25. E. Kutter, D. De Vos, and G. Gvasalia Phage therapy in clinical practice: treatment of human infections Curr Pharm Biotechnol 11 2010 69 86
26. E. Kutter, and A. Sulakvelidze Bacteriophages Biology and Applications 2005 CRC Press Boca Raton, FL
27. S. O'Flaherty, R.P. Ross, W. Meaney, G.F. Fitzgerald, M.F. Elbreki, and A. Coffey Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals Appl Environ Microbiol 71 2005 1836 1842
28. D. Scholl, S. Rogers, S. Adhya, and C.R. Merril Bacteriophage K1-5 encodes two different tail fiber proteins, allowing it to infect and replicate on both K1 and K5 strains of Escherichia coli J Virol 75 2001 2509 2515
29. N. Cerca, R. Oliveira, and J. Azeredo Susceptibility of Staphylococcus epidermidis planktonic cells and biofilms to the lytic action of staphylococcus bacteriophage K Lett Appl Microbiol 45 2007 313 317
30. D.L. Miller, S. Balter, and R.G. Dixon Quality improvement guidelines for recording patient radiation dose in the medical record for fluoroscopically guided procedures J Vasc Interv Radiol 23 2012 11 18